Redgen

Paper Summary:

This paper reviews a lab report on three experiments testing a new product called Redgen, meant to mirror the action of erythropoietin, a protein made by the kidney to stimulate the production of red blood cells. The paper discusses how having developed Redgen, the company now has to test it and to demonstrate that it is analogous to erythropoietin and provides similar benefits to the patient. To demonstrate this, the paper reviews three experiments that have been conducted to show the different aspects of the product and ways in which Redgen acts as effectively as erythropoietin.

From the Paper:

"To develop a synthetic analog for erythropoietin, a protein made by the kidney to stimulate the production of red blood cells. Use: The hormone serves in the treatment of kidney failure, for some patients develop anemia when their production of erythropoietin diminishes. Treatment: To allow for treating this condition, the company has developed a product called Redgen to achieve the same benefits as erythropoietin by imitating the action of that hormone. Redgen is acquired from bone marrow cells in culture. "

More papers on Redgen:

• Essay # 88722 : "Synthetic Analogs of Erythropoietin"

APA Citation:

MLA Citation: